Hemispherx Biopharma (HEB) Appoints Peter W. Rodino III, Esq. to the Board of Directors and to Serve as Chairman of the Company's Audit Committee
7/29/2013 8:59:57 AM
Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!
PHILADELPHIA, July 29, 2013 (GLOBE NEWSWIRE) -- Hemispherx Biopharma, Inc. (NYSE MKT:HEB) (the "Company" or "Hemispherx"), announced that effective July 23, 2013, the Board of Directors of Hemispherx approved the appointment of Peter W. Rodino III as a Director of the Company. Mr. Rodino was also appointed as Chairman and Financial Expert of the Audit Committee, a member of the Compensation Committee and a member of the Governance and Nomination Committee of the Board of Directors. Mr. Rodino will serve as a Director until the Company's next annual meeting of shareholders. These changes were the result of the previously announced recent resignation of Richard C. Piani due to health reasons.
Help employers find you! Check out all the jobs and post your resume.
comments powered by